This systematic review evaluates the use of methylene blue (MB) in managing vasoplegic shock, particularly in critical care, liver transplantation, and cardiac anesthesia. While MB has shown consistent blood pressure improvement in small studies and case reports, its effect on mortality and oxygen delivery remains inconclusive. The review stresses the
This meta-analysis and expert panel discussion evaluated the safety of topical estrogen (TE) therapy in breast cancer survivors undergoing adjuvant endocrine treatment with tamoxifen (TAM) or aromatase inhibitors (AIs). Analyzing six observational studies with 38,050 patients, including 1,805 exposed to TE, the study found that TE use with TAM did
This article reviews the cardiovascular risks associated with testosterone (T) therapy, highlighting the ongoing debate about its safety. While some studies suggest an increased risk of cardiovascular events, many others indicate that maintaining normal testosterone levels has beneficial effects on cardiovascular health, such as reduced mortality and a decrease in
This cohort study investigated the impact of low protein intake on IGF-1 levels, cancer risk, and overall mortality in individuals aged 50-65 and older. It found that reducing protein intake significantly lowered IGF-1 levels and was associated with a decrease in cancer and mortality risk in younger adults (≤65 years),
This article reviews the benefits of hormone replacement therapy (HRT) for postmenopausal women, specifically in reducing the risk of coronary heart disease (CHD) and improving overall mortality. The study supports the “timing hypothesis,” indicating that initiating HRT shortly after menopause (within 10 years or before age 60) provides significant benefits,
The study titled “Benefits and Harms of Antihypertensive Treatment in Low-Risk Patients With Mild Hypertension” was published in JAMA Internal Medicine in December 2018 (PMID: 30383082). This observational cohort study analyzed data from the Clinical Practice Research Datalink, focusing on patients aged 18 to 74 years with untreated mild hypertension
This cohort study from the UK Biobank analyzed the relationship between physical activity and the risk of mortality and cardiovascular disease (CVD) in 130,000 participants. It found that even small amounts of exercise, such as 150 minutes per week, significantly reduced the risk of death from all causes and CVD,
